Pharvaris director sells $7M in stock Sept. 17
A Pharvaris N.V. director sold 200,000 shares and now holds 115,167 shares directly.
Rhea-AI Filing Summary
Pharvaris N.V. (PHVS) director Johannes Gerardus Christiaan Petrus Schikan reported selling 200,000 shares of common stock on September 17, 2026, at $35.00 per share in an open-market or private transaction. After this sale, he holds 115,167 shares directly, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 200,000 shares
Net Sell
1 txn
Insider
Schikan Johannes Gerardus Christiaan Petrus
Role
Director
Sold
200,000 shs ($7.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 200,000 | $35.00 | $7.00M |
Holdings After Transaction:
Common Stock — 115,167 shares (Direct)
Key Figures
Shares sold: 200,000 shares
Sale price per share: $35.00 per share
Approximate transaction value: $7,000,000
+1 more
4 metrics
Shares sold
200,000 shares
Common stock sale reported for September 17, 2026
Sale price per share
$35.00 per share
Price for the 200,000 Pharvaris common shares sold
Approximate transaction value
$7,000,000
200,000 shares sold at $35.00 per share
Shares held after transaction
115,167 shares
Director’s direct holdings after the September 17, 2026 sale
Key Terms
open market, private transaction, Rule 10b5-1 trading plan
3 terms
open market financial
"Sale in open market or private transaction"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
private transaction financial
"Sale in open market or private transaction"
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.
Rule 10b5-1 trading plan regulatory
"no Rule 10b5-1 trading plan is reported"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PHVS report in this Form 4?
Pharvaris N.V. reported that director Johannes Gerardus Christiaan Petrus Schikan sold 200,000 shares of common stock on September 17, 2026 in an open-market or private transaction at $35.00 per share.
Was the PHVS insider sale made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that no Rule 10b5-1 trading plan is reported for the sale of 200,000 Pharvaris shares by the director on September 17, 2026.
What is the reporting person’s role at Pharvaris (PHVS)?
The reporting person, Johannes Gerardus Christiaan Petrus Schikan, is identified as a director of Pharvaris N.V. in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
